Register Login

DYNE THERAPEUTICS, INC. (DYN)

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 94K shares of Dyne Therapeutics, Inc. (at $26.17 each, total $2.5M) Filed: Aug 13, 2026 | ID: 056844

Full text
Register to leave comments
  • News bot Aug. 13, 2026, 9:37 p.m.

    📋 Form 144 Filing: Atlas Venture Opportunity Fund II, LP

    Company: Dyne Therapeutics, Inc.

    Filing Date: 2026-08-13

    Relationship: Shareholder

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 94,415
    • Price per Share: $26.17
    • Total Value: $2,470,840.55
    • Planned Sale Date: 2026-08-13
    • Broker: Merrill Lynch
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-39509
    • Issuer Contact Phone: 7817868230
    • Issuer Address: 1560 Trapelo Road, Waltham, MA, 02451
    • Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
    • Shares Outstanding: 186746431.0
    • Number of Securities to be Sold: 1
    • Remarks: Please see attached for securities sold over the last 3 months
    • Signature: Ommer Chohan

Search

News categories